Form 4: Director Robert D. Straus Receives NATR Equity Grant

Nature's Sunshine Products director Robert D. Straus was granted 4,500 restricted stock units as part of an equity compensation plan.

Summary

• Director Robert D. Straus acquired 4,500 restricted stock units (RSUs) of Nature's Sunshine Products, Inc. (NATR).
• The transaction occurred on May 15, 2026.
• Each RSU represents the right to receive one share of common stock upon vesting.
• Following this transaction, the director's total beneficial ownership increased to 56,514 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market volatility and the future performance of NATR common stock.

Future Outlook

The RSUs are scheduled to vest on the earlier of May 15, 2027, or the date of the company's next annual shareholder meeting.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder value in the consumer health and wellness sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for mid-cap companies in the health and wellness industry.
• The vesting schedule of one year or the next annual meeting is a common retention and alignment mechanism.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of director incentives with company performance.

Next Steps

• Vesting of the 4,500 RSUs on May 15, 2027, or the date of the annual shareholder meeting.

Key Dates

Keywords

NATR, Nature's Sunshine Products, Form 4, Insider Trading, Equity Compensation, Director